Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition.

Dec 8, 2024 0 1.5k
Jan 28, 2025 0 380
Nov 21, 2024 0 271
May 7, 2024 0 244
Apr 15, 2024 0 232
News headlines uses cookies. By continuing to browse the site you are agreeing to our TERMS and to use of cookies.